The War On Ivermectin

A new book titled “The War On Ivermectin” by Dr. Pierre Kory and Jenna McCarthy delves into the history of Ivermectin during the COVID-19 pandemic in the United States.

Today lets talk a bit about the history of the use of Ivermectin for treating COVID-19, and in particular the new book which will be out in just a few days from Dr. Pierre Kory and Jenna McCarthy titled “The War on Ivermectin”.

To kick this off, there is a fake/fabricated storyline circulating that the US DoD/DTRA- Chem-Bio defense (DOMANE) program actively suppressed the use of Ivermectin as a COVID-19 treatment option, that I was the leader of the DOMANE program, and that I am personally responsible for the advancement and licensure of Remdesivir and the suppression of Ivermectin as a treatment option. The same self-styled “independent journalist” promoting these obvious falsehoods also asserts that I am responsible for 9-11 and the Anthrax attacks.

The following paragraphs are the first time I have directly addressed aspects of my involvement in drug repurposing for COVID involving Ivermectin.

Historically I primarily have spoken out about the COVID genetic vaccines, because that is what people (and podcasters) wanted to hear from me. But that work is only a small subset of my efforts to provide ways to mitigate the damages caused by SARS-CoV-2, COVID-19 and the COVID crisis response since January of 2020. My work in repurposing drugs for early COVID-19 treatment, which consumed all of 2020 and most of 2021, is not something that I have emphasized in my public activities for three general reasons: First, others have spoken at length about their work, so the topic of drug repurposing has been fairly well covered. Second, much of my work was performed as a consultant/subcontractor under various non-disclosure agreements. Nothing nefarious here, just normal business practices for a small consulting shop. Third, despite what some may darkly mutter, my public activities have not been about self-promotion, but rather have been focused on trying to educate and help the general public deal with the upside down clown world of the COVIDcrisis public response that they have been subjected to since January 2020.

I have a general rule of thumb to not talk to the crazies, online or otherwise, and so have not previously felt any particular need to address these various unfounded conspiracy theories promoted by a self-styled “independent journalist” who mostly seems to be obsessed with trying to belittle, gaslight, and denigrate me without bothering to actually do the investigative research which would immediately refute his theories. I have no idea who pays this person to spread his theories and attacks on me and many others.

For the record,

• DOMANE is a DoD/DTRA program. I have never been a DTRA employee. I have never been a member of DTRA (or DOMANE) leadership. All lies. In my role as CEO of my consulting business RWMaloneMD LLC I served as a subcontractor for three DTRA-related contracts. One contract was issued to a small company called Allchem, which at the time was owned by Dr. Jim Talton. That contract was focused on discovering inhibitors of organophosphate toxins (nerve gases and certain pesticides) using high throughput computational and robotic screening methods. The other contract was with MIT Lincoln Lab, where I served as a consultant on that DOMANE contract, which was focused on discovering repurposed drugs for treatment of COVID-19 (including Ivermectin) and advancing sponsored clinical research to test those agents. The third one (also acting as a consultant/subcontractor) was managed by Leidos, and involved development of an advanced patient-centered outcomes research software tool and use in supporting both outpatient (virtual) clinical trials as well as parallel inpatient trials of the repurposed pharmaceutical agents ivermectin, celecoxib, and famotidine. No Remdesivir. Amazingly, the FDA blocked that program (and the DoD) from testing Ivermectin, informing that clinical trials of that agent would not be allowed to proceed until in vitro (in the test tube) studies demonstrated the mechanism of action of Ivermectin as an anti-viral for SARS-CoV-2.
• DOMANE is not the program which advanced and advocated Remdesivir for COVID-19. Another obvious lie. That would be Dr. Anthony Fauci and the NIAID. The historic record is clear on that. DOMANE leadership claims credit for funding the initial development of Remdesivir because it funded the development of this drug as a potential anti-Ebola agent, for which application it failed largely due to toxicity and lack of effectiveness.
• I was an early and continued advocate for use of Ivermectin for treatment of COVID-19. Some, although not this particular “investigative journalist” in question, will remember that I was specifically attacked by “independent journalist” Mr. Alex Berenson for my advocacy of the repurposed agent as a treatment for COVID-19. Reviewing my over 3,400 email correspondences involving Ivermectin since January 01, 2020 (there were many more before that date), I find that the first in this time frame is dated January 10, 2020, and involved internal correspondence with the Alchem team (who were volunteering their time to try to identify repurposed drugs for SARS-CoV-2 treatment). Most are also not aware that further back in time I had been an advocate for the use of Ivermectin as an agent for treating Yellow Fever Virus infection and many other viruses, and even filed a field of use patent (since abandoned) for Ivermectin as an antiviral.
• Searching my email accounts for the key words “Ivermectin” and “Kory” (as in Pierre) reveals 936 email correspondences, the first being on 11/19/2020 (almost 200 days prior to the Bret Weinstein/Pierre Kory DarkHorse Podcast. This first notification of the potential efficacy of Ivermectin was part of a summary provided by senior (since retired) DTRA/DOMANE scientist Dr. Howard Haimes. On December 08, 2020, I wrote to the project officer for the DTRA/DOMANE contractor Leidos concerning the following article posted on Trial Site News, and advocating for clinical testing of Ivermectin within the funded program:

Prominent Physician/Researchers to Present Case for Ivermectin to U.S. Senate Committee on Homeland Security & Governmental Affairs

The U.S. Senate Committee on Homeland Security & Governmental Affairs will hold a full committee hearing on December 8, 2020, at 10:00 AM at the Senate Dirksen Building and via video conference. Titled “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II,” invited witnesses to include Jane M. Orient, MD, Executive Director Association of American Physicians and Surgeons, Pierre Kory, MD, Associate Professor of Medicine, St. Luke’s Aurora Medical Center, Jean-Jacques Rajter, MD, Pulmonologist, Broward Health Medical Center and ICON study co-author and Ramin Oskoui, MD, Vice President of Medical Staff, Sibley Memorial Hospital and Chief Executive Officer of Foxhall Cardiology. Prominent among discussion topics will be the use of ivermectin as a treatment for early-stage, mild to moderate COVID-19 cases. To date, although well over $12 billion U.S. dollars have been spent by the taxpayers, there has been no breakthrough for early-stage treatment, an incredibly important period to get COVID-19 under control. There is evidence that some generic-based treatments can help accomplish this objective.

Swedish researchers reported in a study published in the British Medical Journal that mRNA COVID-19 vaccines are linked to an increased risk of vaginal bleeding.

Read more